Calendar Eliem Therapeutics, Inc.

Equities

ELYM

US28658R1068

Market Closed - Nasdaq 01:30:00 03/05/2024 am IST 5-day change 1st Jan Change
8.39 USD +10.83% Intraday chart for Eliem Therapeutics, Inc. +129.23% +210.74%

Chart calendar Eliem Therapeutics, Inc.

cd6.IqJm_yGPPaFhKnRWU61V2i8awMpU8_AuVBJuOJCJkOk.VcEkmW_MDsk4QhknC_IZgmxb8PMVu5N9OyMZdKLr-qx99gWHDMZyzwR7Hw~c4a7fd11072e208316aa2a71feb1b5d0

Upcoming events on Eliem Therapeutics, Inc.

13/05/2024 Q1 2024 Earnings Release (Projected)

Past events on Eliem Therapeutics, Inc.

11/04/2024 06:00 pm Acquisition of Tenet Medicines Inc by Eliem Therapeutics Inc Call
13/09/2023 International Kv7 Channels Symposium
31/05/2023 Epilepsy Therapies & Diagnostics Development Conference
18/05/2023 Annual General Meeting
12/05/2023 01:40 am Q1 2023 Earnings Release
27/03/2023 RSC BMCS SCI Symposium
07/03/2023 02:40 am Q4 2022 Earnings Release
01/12/2022 10:10 pm Evercore ISI HealthCONx Conference
17/11/2022 12:20 am Stifel Healthcare Conference
15/11/2022 08:40 pm Guggenheim Immunology and Neurology Conference
14/11/2022 04:40 pm Q3 2022 Earnings Release
15/08/2022 03:40 pm Interim 2022 Earnings Release
21/07/2022 08:00 pm Investor Meeting
19/05/2022 10:30 pm Annual General Meeting
16/05/2022 03:40 pm Q1 2022 Earnings Release
29/03/2022 07:00 pm Stifel CNS Day
08/03/2022 02:40 am FY 2021 Earnings Release
19/02/2022 01:30 am SVB Leerink Global Healthcare Conference
16/02/2022 09:00 pm Investor Meeting
02/12/2021 01:35 am Evercore ISI HealthCONx Conference

Annual results

Fiscal PeriodDecember 2020 2021 2022
Net sales
Million USD
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
0,00


-35,7
-38,0
6%
-45,1
-46,3
2.43%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-47,5
-49,9
4.85%
-45,2
-48,2
6.05%
Net income
Million USD
Released
Forecast
Spread
-20,7


-52,0
-57,5
9.46%
-45,2
-47,4
4.63%
EPS
USD
Released
Forecast
Spread
-5,25


-4,24
-6,32
32.91%
-1,72
-1,73
0.39%
Announcement Date21/06/2107/03/2206/03/23

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-10,7
-13,0
17.35%
-13,1
-15,2
13.32%
-13,7
-13,1
-4.59%
-8,75
-13,5
34.96%
-9,55
-8,80
-8.57%
-23,4
-7,79
-200.78%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-10,5
-13,0
18.57%
-13,2
-15,2
12.84%
-14,6
-13,1
-11.42%
-9,68
-13,5
28.01%
-7,76
-8,80
11.8%
-22,3
-7,79
-186.04%
Net income
Million USD
Released
Forecast
Spread
-10,5
-16,0
33.96%
-13,2
-14,8
10.78%
-14,6
-12,4
-18.03%
-9,68
-12,6
23.16%
-7,76
-8,65
10.27%
-22,3
-6,63
-236.28%
EPS
USD
Released
Forecast
Spread
1,25
-0,63
298.41%
-0,50
-0,56
11.24%
-0,56
-0,47
-20%
-0,37
-0,43
14.45%
-0,29
-0,33
13%
-0,84
-0,25
-236%
Announcement Date07/03/2216/05/2215/08/2214/11/2206/03/2311/05/23

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ELYM Stock
  4. Calendar Eliem Therapeutics, Inc.